s.chowdhury
TL3 Regular · Dhaka, BD
Biochemistry postgraduate. I help with the chemistry explanations when they get too jargon-heavy.
Joined 27 October 2024 · last posted 16h · groups: wiki-editors, translators
207 posts, newest first. Showing up to 150.
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #31 · Sourcing › Vendor reports · 27 Jul 2026 · 0 likes A definition problem is doing most of the work in this Reconciling a supplier certificate discussion. Once the term is pinned down I suspect the disagreement mostly…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #19 · Compounds › Oral incretins · 23 Jul 2026 · 0 likes Answering the PIONEER 6 cardiovascular safety question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends…
-
Seven-day rolling means and why weekly readings mislead Replied, post #89 · Outcomes › Progress reports · 23 Jul 2026 · 18 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend.
-
An 18-month record including the parts that went badly Replied, post #77 · Outcomes › Progress reports · 22 Jul 2026 · 0 likes Post #74 is the version of this I will quote in future. One addition. An observation about 18-month record that I cannot explain and am posting anyway, on the principle…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #47 · Analytics › Method validation · 22 Jul 2026 · 0 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. Adding it in case it saves…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #20 · Analytics › COA interpretation · 21 Jul 2026 · 4 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #110 · Compounds › Semaglutide · 18 Jul 2026 · 17 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
GLP-1 receptor distribution: central and peripheral Replied, post #91 · Pharmacology › Receptor biology · 16 Jul 2026 · 0 likes Where I part company with post #89, and it is a narrow parting. Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to…
-
NHS criteria and how they are applied in practice Replied, post #30 · Regional › UK & Ireland · 15 Jul 2026 · 12 likes Post #27 answers the question as asked. The question underneath it is different. A note on how NHS criteria gets discussed rather than on NHS criteria itself: the…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #36 · Practice › Interactions · 12 Jul 2026 · 0 likes I have been on both sides of the Antibiotics argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #15 · Start Here › How to Ask · 11 Jul 2026 · 9 likes When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on whether the number came from a certificate, an…
-
Pancreatitis history and the risk calculus Replied, post #27 · Safety › Contraindications · 10 Jul 2026 · 24 likes The failure mode on pancreatitis history is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #42 · Practice › Side effects · 7 Jul 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
How much context is too much context in a first post? Replied, post #19 · Start Here › How to Ask · 5 Jul 2026 · 4 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. I…
-
Micro-titration: a disputed topic, argued properly Replied, post #99 · Practice › Dosing & titration · 3 Jul 2026 · 1 like Post #98 is right about the mechanism and I think understates the practical bit. The most useful reply I ever got about micro-titration was a request to state my units.…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #92 · Compounds › Semaglutide · 3 Jul 2026 · 18 likes Coming back to post #90, because the follow-up matters more than the original answer. Research-use-only semaglutide is not a licensed medicine, is not manufactured to…
-
NHS criteria and how they are applied in practice Replied, post #18 · Regional › UK & Ireland · 3 Jul 2026 · 7 likes Coming back to post #14, because the follow-up matters more than the original answer. NHS access has been restricted by commissioning criteria, not by licensing.…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #72 · Analytics › Method validation · 30 Jun 2026 · 0 likes Post #69 is the version of this I will quote in future. One addition. Whatever the answer on Specificity turns out to be, the method for getting there is the same:…
-
What a reversed-phase purity number actually is Replied, post #12 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 5 likes Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280 it sees aromatic residues, so a peptide without tryptophan or…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #51 · Sourcing › Independent verification · 29 Jun 2026 · 10 likes Noted, and I have changed what I was going to do on the strength of it.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #99 · Evidence › Journal club · 27 Jun 2026 · 0 likes Confirming post #97 from a second method, which matters more than confirming it from a second person. The figures usually contain the finding and the text usually…
-
What a regulator's shortage notice actually authorises Replied, post #2 · Sourcing › Regulatory · 27 Jun 2026 · 23 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #75 · Compounds › Semaglutide · 23 Jun 2026 · 10 likes I had written a reply contradicting post #72 and deleted it. Here is what survived. Offering a way to settle semaglutide and gastric emptying rather than another…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #8 · Clinical › Comorbidities · 23 Jun 2026 · 0 likes Adding the measurement that post #7 says would settle it. A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake,…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #56 · Start Here › How to Ask · 20 Jun 2026 · 10 likes Post #53 answers the question as asked. The question underneath it is different. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #107 · Practice › Reconstitution · 14 Jun 2026 · 2 likes Post #105 and I disagree about the size of the effect, not about the direction. Write the reconstitution date and the concentration on the vial. Not on a note, on the…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #13 · Access › International · 13 Jun 2026 · 13 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Why the cheapest option is often not the cheapest Replied, post #9 · Access › Pricing · 13 Jun 2026 · 3 likes Where somebody posts a comparison, the useful version states the date, the region and what was included.
-
Micronutrient adequacy at low total intake Replied, post #66 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 31 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Request: a per-category review queue Replied, post #30 · Meta › Feature requests · 11 Jun 2026 · 0 likes The version of per-category review queue that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #73 · Evidence › Preprints · 8 Jun 2026 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Always label it as a preprint in any discussion. A preprint is not a published trial and it…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #23 · Sourcing › Independent verification · 6 Jun 2026 · 1 like Post #20 answers the question as asked. The question underneath it is different. The honest answer on Janoshik is that it depends, and the useful part is the list of…
-
Injecting into an area that has become firm: why not to Replied, post #17 · Practice › Administration · 5 Jun 2026 · 6 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I would…
-
Prescription portability between countries Replied, post #53 · Access › International · 4 Jun 2026 · 2 likes Comparing prices across countries without accounting for what is included — device, needles, dispensing — produces comparisons that are not comparisons. The reasoning…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #49 · Analytics › HPLC & UHPLC · 27 May 2026 · 0 likes Narrowing post #46, because the general version has more than one answer. Genuine question rather than a rhetorical one: has anyone here actually observed Area percent…
-
Blind submission and why it changes minds — the long version Replied, post #101 · Sourcing › Independent verification · 27 May 2026 · 2 likes Post #97 and I disagree about the size of the effect, not about the direction. Answering the Blind submission question as asked, then the question I think is meant. As…
-
Prescription requirements and telehealth models — a second dataset Replied, post #42 · Sourcing › Regulatory · 26 May 2026 · 13 likes The strongest argument against my own position on Prescription requirements and telehealth models, stated as well as I can state it, since nobody else has yet.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #25 · Analytics › Method validation · 18 May 2026 · 12 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.
-
Forced degradation studies: designing one that is informative Replied, post #57 · Analytics › Method validation · 16 May 2026 · 14 likes Worth separating two things that post #54 runs together. Forced degradation under acid, base, oxidation, heat and light is how specificity is actually demonstrated. The…
-
What to include when your question involves a chromatogram — one year on Replied, post #7 · Start Here › How to Ask · 16 May 2026 · 5 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop.
-
Reading a trial's population section before its results Replied, post #21 · Evidence › Trials · 14 May 2026 · 12 likes Post #20 answers the question as asked. The question underneath it is different. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Clearance pathways and what renal impairment changes Replied, post #15 · Pharmacology › Pharmacokinetics · 13 May 2026 · 0 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.
-
About the Announcements category Replied, post #5 · Meta › Announcements · 13 May 2026 · 27 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements. The claim is narrower than it sounds,…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #19 · Analytics › COA interpretation · 10 May 2026 · 19 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #45 · Practice › Reconstitution · 9 May 2026 · 14 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #74 · Evidence › Trials · 5 May 2026 · 10 likes Subgroup analyses was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Where to report an adverse event officially, by region Replied, post #2 · Safety › Adverse events · 5 May 2026 · 7 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Request: show the solution author in the topic list — what changed since Replied, post #92 · Meta › Feature requests · 4 May 2026 · 9 likes I had written a reply contradicting post #90 and deleted it. Here is what survived. Then the honest version is a comparison of the record shapes rather than the scores.…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #52 · Evidence › Journal club · 1 May 2026 · 0 likes Worth separating two things that post #49 runs together. Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to…
-
A parcel stationary at a customs facility for nine days Replied, post #54 · Sourcing › Logistics · 30 Apr 2026 · 0 likes A parcel held for a documentation query usually moves once the document is provided. Chasing the carrier before the query is answered achieves little.
-
Prescription portability between countries Replied, post #19 · Access › International · 29 Apr 2026 · 4 likes Confirming post #16 from a second method, which matters more than confirming it from a second person. The most useful reply I ever got about prescription portability…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #114 · Practice › Reconstitution · 27 Apr 2026 · 6 likes I came in to disagree and I am leaving without a disagreement.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #120 · Pharmacology › Pharmacokinetics · 27 Apr 2026 · 12 likes Post #118 put the caveat in the right place and I want to underline it. Washout is a good example of a question where the honest answer is boring and the interesting…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #47 · Evidence › Journal club · 25 Apr 2026 · 0 likes Since orforglipron phase 2 keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #37 · Evidence › Preprints · 23 Apr 2026 · 30 likes Thank you — that answers what I came here to find out.
-
List price versus negotiated price versus what you pay Replied, post #91 · Access › Pricing · 15 Apr 2026 · 1 like List price versus negotiated price was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
List price versus negotiated price versus what you pay Replied, post #72 · Access › Pricing · 14 Apr 2026 · 1 like Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Grapefruit: why this class is not the class that cares Replied, post #110 · Practice › Interactions · 2 Apr 2026 · 10 likes Trying to state the grapefruit position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #33 · Start Here › Welcome · 31 Mar 2026 · 25 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #39 · Practice › Administration · 28 Mar 2026 · 17 likes Understood, and I withdraw the assumption I opened with.
-
Journal club: is percentage weight change the right endpoint? Replied, post #19 · Evidence › Journal club · 27 Mar 2026 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #74 · Practice › Interactions · 27 Mar 2026 · 6 likes I would be cautious about generalising from the Metformin co-administration example above. It is a good example. It is one example.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #95 · Research Methods › N-of-1 designs · 23 Mar 2026 · 0 likes Post #91 put the caveat in the right place and I want to underline it. Order effects matter. If you always try A before B, you cannot separate the treatment from the…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #87 · Regional › UK & Ireland · 22 Mar 2026 · 32 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #26 · Start Here › Welcome · 16 Mar 2026 · 18 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Adolescents: a distinct evidence base — one year on Replied, post #75 · Clinical › Special populations · 15 Mar 2026 · 7 likes This is the answer, and the reason it is the answer is the more useful part.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #16 · Evidence › Journal club · 14 Mar 2026 · 1 like Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I have said this before in a thread nobody could…
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #2 · Compounds › Retatrutide · 14 Mar 2026 · 3 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #111 · Access › Pricing · 10 Mar 2026 · 0 likes Post #109 and I disagree about the size of the effect, not about the direction. Reading back through the Price changes threads from last year, the same three questions…
-
Why this subcategory is stricter about sourcing than most Replied, post #5 · Compounds › Secretagogues & GH axis · 4 Mar 2026 · 6 likes Reconstitution volumes in this family are often small enough that dead volume in the syringe is a meaningful fraction of the dose. A fixed-needle insulin syringe is…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #7 · Practice › Reconstitution · 1 Mar 2026 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 26 Feb 2026 · 0 likes On analysis: an amylin analogue and its aggregates are not equally detectable by a standard reversed-phase method, because a large aggregate may not elute at all. Area…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #40 · Practice › Reconstitution · 20 Feb 2026 · 20 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #118 · Access › International · 19 Feb 2026 · 4 likes The claim about Language barriers in accessing upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post…
-
Interim analyses and stopping rules Replied, post #13 · Evidence › Trials · 15 Feb 2026 · 13 likes Answering the interim analyses and stopping rules question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it…
-
Revisiting: Maintainer handover: how it works Started this topic · Meta › Wiki maintenance · 14 Feb 2026 · 0 likes Revisiting: Maintainer handover: how it works Writing it up because I had to work it out twice and would rather nobody else did. Maintainer handover keeps being…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #4 · Clinical › Comorbidities · 14 Feb 2026 · 0 likes Where I part company with post #2, and it is a narrow parting. Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of…
-
Angle of injection and whether 90 degrees is always right Replied, post #99 · Practice › Administration · 13 Feb 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. The…
-
The most useful thing you learned here that was not the answer you came for Replied, post #20 · Lounge › Off topic · 12 Feb 2026 · 21 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #18 · Practice › Administration · 10 Feb 2026 · 22 likes Picking up post #15: that is the part I would want checked first. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #27 · Research Methods › Statistics · 7 Feb 2026 · 11 likes Where the Measurement error in home scales reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #47 · Practice › Storage & stability · 1 Feb 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Managing an unplanned gap in supply Replied, post #19 · Access › Shortages · 31 Jan 2026 · 14 likes Picking up post #16: that is the part I would want checked first. I would put moderate confidence on the mainstream reading of managing an unplanned gap and no more.…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #3 · Analytics › HPLC & UHPLC · 25 Jan 2026 · 0 likes I changed my mind about Area percent versus weight percent after someone here asked me for the source and I could not produce one. That is worth saying out loud because…
-
A payment that went through twice: how it was resolved Replied, post #15 · Sourcing › Payments · 22 Jan 2026 · 18 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #2 · Practice › Storage & stability · 21 Jan 2026 · 16 likes Answering the question the opening post raises rather than the one it answers. The honest summary: keep it dry until you need it, keep it cold once it is not, keep it…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #114 · Analytics › COA interpretation · 20 Jan 2026 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #5 · Evidence › Journal club · 19 Jan 2026 · 9 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #45 · Devices › Pens & autoinjectors · 17 Jan 2026 · 1 like Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than people expect.
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #9 · Analytics › Mass spectrometry · 15 Jan 2026 · 5 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Guidelines revision: what changed and why — one year on Replied, post #57 · Meta › Announcements · 12 Jan 2026 · 8 likes Post #56 describes the usual case. This is about the unusual one. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #129 · Documentation › Doc review · 9 Jan 2026 · 11 likes On post #125 — agreed on the reasoning, with one qualification. Promotion criteria: I would want to see the raw numbers rather than the summary before agreeing.…
-
A history of disordered eating: proceeding carefully Replied, post #54 · Wellbeing › Mental health · 8 Jan 2026 · 7 likes A request rather than an answer: could whoever has the primary source for history of disordered eating post it? I have seen the claim three times this month and each…
-
Aggregates and why a purity assay may miss them entirely Replied, post #55 · Analytics › Impurities & related substances · 7 Jan 2026 · 7 likes Adding a reference point for aggregates. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #40 · Regional › UK & Ireland · 5 Jan 2026 · 1 like Post #38 and I disagree about the size of the effect, not about the direction. Waiting times are the most variable and least generalisable thing reported here, and they…
-
Dead volume across syringe and needle combinations Replied, post #48 · Devices › Syringes & needles · 2 Jan 2026 · 10 likes Nothing to add, except that this is the answer I would give if asked.
-
Tag proliferation and whether we should prune — what changed since Started this topic · Meta › Site feedback · 30 Dec 2025 · 0 likes Tag proliferation and whether we should prune — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard…
-
Adolescents: a distinct evidence base — one year on Replied, post #48 · Clinical › Special populations · 28 Dec 2025 · 0 likes Post-surgical populations, particularly after procedures affecting the gastrointestinal tract, interact with a delayed-emptying mechanism in ways that need specialist…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #23 · Practice › Side effects · 27 Dec 2025 · 10 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Request: a diff view for wiki revisions — the long version Replied, post #89 · Meta › Feature requests · 25 Dec 2025 · 2 likes If you are new and reading this thread for the answer to diff view for wiki revisions: the answer is conditional, the conditions are in the third reply, and the rest of…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #25 · Clinical › Bloodwork · 20 Dec 2025 · 5 likes The honest answer on reference intervals is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.…
-
Personal import allowances, compared Replied, post #5 · Access › International · 19 Dec 2025 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
The decimal-point error, and the habit that catches it Replied, post #95 · Practice › Reconstitution · 17 Dec 2025 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #30 · Compounds › Tirzepatide · 16 Dec 2025 · 0 likes The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why that trial carries more weight than its size…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #46 · Sourcing › Vendor reports · 16 Dec 2025 · 1 like Post #45 is the version of this I will quote in future. One addition. The cost of a submission is worth stating. It is the main reason people do not do this and knowing…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #58 · Wellbeing › Mental health · 3 Dec 2025 · 17 likes Trying to state the Anxiety position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Started this topic · Compounds › Tirzepatide · 28 Nov 2025 · 12 likes On the subject in the title: Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long version Working notes rather than a conclusion. A…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #28 · Analytics › Method validation · 24 Nov 2025 · 0 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Request: a diff view for wiki revisions — the long version Replied, post #72 · Meta › Feature requests · 19 Nov 2025 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
High-resolution MS on aggregates and what it can see Replied, post #122 · Analytics › Mass spectrometry · 16 Nov 2025 · 0 likes Reframing high-resolution slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #62 · Compounds › Tirzepatide · 14 Nov 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #26 · Compounds › Tirzepatide · 9 Nov 2025 · 12 likes The titration schedule has more steps than semaglutide's, which reflects the finer gradation used in the clinical programme rather than a pharmacological requirement…
-
Dose numbers across compounds are not on the same scale Replied, post #3 · Practice › Dosing & titration · 2 Nov 2025 · 16 likes Where I part company with the opening post, and it is a narrow parting. Escalating before steady state means you are judging a dose you have not yet fully experienced.…
-
Dead volume across syringe and needle combinations Replied, post #17 · Devices › Syringes & needles · 29 Oct 2025 · 4 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Sleep tracking data and its considerable limitations Replied, post #121 · Wellbeing › Sleep · 29 Oct 2025 · 13 likes Since sleep keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #41 · Wellbeing › Mental health · 23 Oct 2025 · 9 likes Something worth flagging about Anxiety: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Payment mechanics and the recovery options that do not exist Replied, post #66 · Sourcing › Payments · 21 Oct 2025 · 5 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
The headache that turns out to be dehydration Replied, post #30 · Nutrition & Training › Hydration & electrolytes · 21 Oct 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Documentation that materially improves an appeal's chances Replied, post #32 · Access › Insurance & coverage · 18 Oct 2025 · 32 likes On post #30 — agreed on the reasoning, with one qualification. Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #87 · Lounge › Off topic · 10 Oct 2025 · 1 like Adding a data point of agreement rather than a data point.
-
Second pass at: Programming during a large energy deficit Replied, post #32 · Nutrition & Training › Resistance training · 8 Oct 2025 · 1 like A resistance stimulus during a deficit is the other half of the lean-tissue argument, and the evidence for it is reasonably strong.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #95 · Evidence › Preprints · 3 Oct 2025 · 0 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. The right answer here…
-
Insurance and replacement policies, compared — the long version Replied, post #19 · Sourcing › Logistics · 24 Sep 2025 · 0 likes Post #16 is the version of this I will quote in future. One addition. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Started this topic · Compounds › Oral incretins · 19 Sep 2025 · 49 likes Why oral semaglutide needs an absorption enhancer at all — one year on — that is the question, and I have not found it answered plainly anywhere I have looked. Reading…
-
Tracking that stops updating and then resumes Replied, post #28 · Sourcing › Logistics · 19 Sep 2025 · 20 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Titles that describe the question, not the situation Replied, post #100 · Start Here › How to Ask · 19 Sep 2025 · 23 likes Answering the question post #98 raises rather than the one it answers. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #64 · Practice › Side effects · 15 Sep 2025 · 12 likes Post #63 is right about the mechanism and I think understates the practical bit. The relationship between symptom burden and outcome is not what people assume. Feeling…
-
Titles that describe the question, not the situation — what changed since Replied, post #12 · Start Here › How to Ask · 13 Sep 2025 · 0 likes Taking post #9 at face value and following it one step further. Offering a way to settle Titles rather than another opinion about it. Two measurements, taken the same…
-
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #6 · Evidence › Journal club · 12 Sep 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Persistent vomiting and the threshold for seeking help Replied, post #32 · Safety › Adverse events · 11 Sep 2025 · 15 likes I came in to disagree and I am leaving without a disagreement.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #110 · Data & Tools › Calculators · 9 Sep 2025 · 2 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #28 · Practice › Side effects · 31 Aug 2025 · 7 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
A preprint whose numbers changed substantially at publication Replied, post #34 · Evidence › Preprints · 29 Aug 2025 · 11 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. A partial answer,…
-
Trial registration and comparing the protocol with the paper Replied, post #31 · Evidence › Trials · 20 Aug 2025 · 3 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
A request that was declined, and the reasoning — a second dataset Replied, post #80 · Documentation › Wiki requests · 14 Aug 2025 · 8 likes Post #78 and I disagree about the size of the effect, not about the direction. A request that says what the page should not cover is unusually helpful, because scope…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #19 · Practice › Side effects · 5 Aug 2025 · 0 likes If you are new and reading this thread for the answer to Fatigue: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth…
-
A ten-fold dose error caught before injection — one year on Replied, post #38 · Devices › Syringes & needles · 2 Aug 2025 · 8 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
How to research a compound with no human data without deceiving yourself Replied, post #21 · Compounds › Other compounds · 30 Jul 2025 · 0 likes This follows post #20 rather than contradicting it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #100 · Wellbeing › Mental health · 30 Jul 2025 · 0 likes Adding the measurement that post #99 says would settle it. I keep a log for history of disordered eating specifically because my memory of it turned out to be…
-
A field-by-field walk through a certificate of analysis Replied, post #97 · Analytics › COA interpretation · 17 Jul 2025 · 1 like My position on field-by-field walk through a certificate is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #4 · Sourcing › Regulatory · 13 Jul 2025 · 1 like Two things can be true about compound being unapproved at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Started this topic · Practice › Side effects · 8 Jul 2025 · 13 likes On the subject in the title: The nausea timeline across the first four weeks, with a tabulated log — what changed since Working notes rather than a conclusion. What…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #79 · Compounds › Tirzepatide · 29 Jun 2025 · 7 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
High-resolution MS on aggregates and what it can see Replied, post #13 · Analytics › Mass spectrometry · 28 Jun 2025 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Deamidation adds approximately one dalton and produces a species that frequently…
-
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #16 · Data & Tools › Datasets · 27 Jun 2025 · 9 likes On whether an aggregate, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #17 · Practice › Reconstitution · 27 Jun 2025 · 32 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. A single…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #92 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 0 likes Answering the question post #88 raises rather than the one it answers. Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #95 · Access › Insurance & coverage · 13 Jun 2025 · 1 like Answering the question post #93 raises rather than the one it answers. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #67 · Compounds › Retatrutide · 12 Jun 2025 · 1 like No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
-
Sodium, potassium and magnesium when intake drops Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 7 Jun 2025 · 23 likes Answering the question post #4 raises rather than the one it answers. Fluid intake and electrolyte intake are separate questions and drinking more water alone can make…